NorthCoast Asset Management’s Novo Nordisk NVO Stock Holding History

NorthCoast Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.05M	Sell	42,582 -12,920	-23%	-$625K	0.07%	175
2021 Q2	$2.33M	Sell	55,502 -540	-1%	-$20.9K	0.08%	169
2021 Q1	$1.89M	Sell	56,042 -3,658	-6%	-$130K	0.08%	172
2020 Q4	$2.09M	Sell	59,700 -10,604	-15%	-$367K	0.09%	136
2020 Q3	$2.44M	Sell	70,304 -4,832	-6%	-$161K	0.12%	114
2020 Q2	$2.46M	Sell	75,136 -3,626	-5%	-$116K	0.14%	100
2020 Q1	$2.37M	Sell	78,762 -3,622	-4%	-$108K	0.15%	93
2019 Q4	$2.39M	Sell	82,384 -219,914	-73%	-$6.09M	0.15%	89
2019 Q3	$7.82M	Sell	302,298 -2,168	-0.7%	-$54.8K	0.52%	51
2019 Q2	$7.78M	Sell	304,466 -1,878	-0.6%	-$46.4K	0.5%	53
2019 Q1	$8.01M	Sell	306,344 -139,238	-31%	-$3.42M	0.52%	54
2018 Q4	$10.3M	Buy	445,582 +339,390	+320%	+$7.54M	0.78%	45
2018 Q3	$2.5M	Buy	+106,192	New	+$2.59M	0.15%	90
2017 Q4	–	Sell	-61,762	Closed	-$1.49M	–	195
2017 Q3	$1.49M	Sell	61,762 -62,788	-50%	-$1.42M	0.17%	107
2017 Q2	$2.67M	Sell	124,550 -11,090	-8%	-$224K	0.31%	58
2017 Q1	$2.33M	Buy	135,640 +72,526	+115%	+$1.26M	0.22%	71
2016 Q4	$1.13M	Sell	63,114 -223,896	-78%	-$4.06M	0.11%	126
2016 Q3	$5.97M	Buy	287,010 +114,802	+67%	+$2.85M	0.49%	40
2016 Q2	$4.63M	Sell	172,208 -3,750	-2%	-$103K	0.32%	41
2016 Q1	$4.77M	Buy	175,958 +85,046	+94%	+$2.28M	0.4%	29
2015 Q4	$2.64M	Sell	90,912 -355,290	-80%	-$9.83M	0.17%	66
2015 Q3	$12.1M	Buy	446,202 +37,746	+9%	+$1.07M	0.66%	36
2015 Q2	$11.2M	Sell	408,456 -101,174	-20%	-$2.84M	0.54%	38
2015 Q1	$13.6M	Buy	509,630 +308,756	+154%	+$7.11M	0.64%	36
2014 Q4	$4.25M	Buy	200,874 +12,702	+7%	+$284K	0.21%	55
2014 Q3	$4.48M	Buy	188,172 +17,030	+10%	+$392K	0.22%	52
2014 Q2	$3.95M	Buy	+171,142	New	+$3.78M	0.23%	54
2014 Q1	–	Sell	-118,960	Closed	-$2.2M	–	194
2013 Q4	$2.2M	Buy	118,960 +31,190	+36%	+$544K	0.14%	75
2013 Q3	$1.49M	Buy	87,770 +26,390	+43%	+$444K	0.1%	80
2013 Q2	$951K	Buy	+61,380	New	+$1.02M	0.07%	78

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NorthCoast Asset Management's NVO Position: Q3 2021 in Review

NorthCoast Asset Management reduced its Novo Nordisk (NVO) stake by 23% in Q3 2021, selling an estimated $625K and leaving 42,582 shares worth $2.05M. The position accounts for 0.07% of the portfolio, ranked #175.

NorthCoast Asset Management first reported a position in NVO in Q2 2013 and has held it in 30 quarters since. The position peaked at $13.6M in Q1 2015. 805 funds tracked by Wall St. Rank hold NVO as of Q3 2021.

NorthCoast Asset Management held 42,582 shares of Novo Nordisk worth $2.05M as of Q3 2021.
NorthCoast Asset Management sold 12,920 Novo Nordisk shares in Q3 2021, an estimated $625K.
Novo Nordisk made up 0.07% of NorthCoast Asset Management's portfolio in Q3 2021, its #175 holding.
NorthCoast Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 30 quarters since.
NorthCoast Asset Management's Novo Nordisk position peaked at $13.6M in Q1 2015.
805 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.